Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic ProductsPRNewsWire • 01/06/21
Co-Diagnostics Designs Test to Detect Mutations for New Coronavirus Strain Using CoPrimer™ PlatformPRNewsWire • 12/22/20
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex TestPRNewsWire • 11/25/20
Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex TestsPRNewsWire • 11/17/20
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/17/20
Co-Diagnostics, Inc. Announces Q3 2020 Financial Results Including YTD Net Income per Common Share of $1.07PRNewsWire • 11/16/20
The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)OTC PR Wire • 11/11/20
Co-Diagnostics, Inc. CoPrimers™ Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample ExtractionPRNewsWire • 11/11/20
Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings WebcastPRNewsWire • 11/10/20
Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per SharePRNewsWire • 11/02/20
CoDiagnostics, Inc. (CODX) Gains But Lags Market: What You Should KnowZacks Investment Research • 10/09/20